Romano Brothers AND Company trimmed its position in Lam Research Corporation (NASDAQ:LRCX – Free Report) by 8.8% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 26,510 shares of the semiconductor company’s stock after selling 2,550 shares during the period. Lam Research makes up approximately 1.2% of Romano Brothers AND Company’s portfolio, making the stock its 17th biggest position. Romano Brothers AND Company’s holdings in Lam Research were worth $11,488,000 at the end of the most recent reporting period.
Other institutional investors have also added to or reduced their stakes in the company. Brighton Jones LLC grew its position in Lam Research by 1,032.4% in the 4th quarter. Brighton Jones LLC now owns 14,189 shares of the semiconductor company’s stock valued at $1,025,000 after purchasing an additional 12,936 shares during the period. Caxton Associates LLP acquired a new position in Lam Research during the first quarter worth $239,000. Gabelli Funds LLC acquired a new position in Lam Research during the second quarter worth $253,000. NewEdge Advisors LLC lifted its stake in shares of Lam Research by 2.7% in the second quarter. NewEdge Advisors LLC now owns 100,528 shares of the semiconductor company’s stock valued at $9,785,000 after buying an additional 2,661 shares in the last quarter. Finally, Osterweis Capital Management Inc. grew its holdings in shares of Lam Research by 5,206.7% during the second quarter. Osterweis Capital Management Inc. now owns 796 shares of the semiconductor company’s stock valued at $77,000 after buying an additional 781 shares during the last quarter. 84.61% of the stock is owned by institutional investors and hedge funds.
Lam Research Trading Up 1.1%
Shares of Lam Research stock opened at $310.53 on Friday. The firm has a market cap of $388.57 billion, a PE ratio of 53.91, a P/E/G ratio of 1.22 and a beta of 1.84. Lam Research Corporation has a 1 year low of $94.11 and a 1 year high of $438.50. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.63 and a quick ratio of 1.91. The stock has a fifty day moving average price of $338.53 and a 200-day moving average price of $285.89.
Analyst Ratings Changes
Several equities research analysts have recently commented on LRCX shares. Cantor Fitzgerald set a $500.00 target price on shares of Lam Research and gave the stock an “overweight” rating in a research report on Monday, June 29th. Sanford C. Bernstein raised their target price on Lam Research from $325.00 to $340.00 and gave the company an “outperform” rating in a report on Thursday, May 21st. BNP Paribas Exane upped their price target on Lam Research from $250.00 to $260.00 and gave the stock a “neutral” rating in a report on Thursday, April 23rd. HSBC reiterated a “hold” rating and issued a $333.00 target price on shares of Lam Research in a report on Monday, July 27th. Finally, Seaport Research Partners began coverage on shares of Lam Research in a research report on Monday, May 4th. They set a “buy” rating and a $300.00 price target on the stock. One research analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, Lam Research currently has a consensus rating of “Moderate Buy” and an average target price of $358.47.
View Our Latest Analysis on LRCX
Insider Activity
In other news, Director Eric Brandt sold 54,500 shares of the firm’s stock in a transaction that occurred on Thursday, June 11th. The shares were sold at an average price of $350.80, for a total transaction of $19,118,600.00. Following the completion of the sale, the director owned 199,205 shares in the company, valued at $69,881,114. This trade represents a 21.48% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Neil J. Fernandes sold 7,659 shares of Lam Research stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $309.60, for a total transaction of $2,371,226.40. Following the completion of the sale, the senior vice president directly owned 58,470 shares in the company, valued at $18,102,312. This trade represents a 11.58% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 80,441 shares of company stock valued at $27,614,296 in the last three months. Company insiders own 0.31% of the company’s stock.
Lam Research Profile
Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
See Also
- Five stocks we like better than Lam Research
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCX – Free Report).
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
